Abstract
WE reported recently1 that purified adeno-associated viruses (types 1 and 2) did not influence the oncogenicity of adenovirus 12 when mixtures were inoculated into newborn hamsters. Kirschstein et al.2 have reported contradictory results in very similar experiments. We were kindly informed (by Dr M. D. Hoggan, National Institutes of Health) that the preparations we used for purification consistently showed low or no infectivity titres, despite containing high concentrations of particles banding at the appropriate density.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gilden, R. V., Kern, J., Beddow, T. G., and Huebner, R. J., Nature, 219, 80 (1968).
Kirschstein, R. L., Smith, K. O., and Peters, E. A., Proc. Soc. Exp. Biol. and Med., 128, 670 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GILDEN, R., KERN, J., BEDDOW, T. et al. Oncogenicity of Mixtures of Adeno-associated Virus and Adenovirus Type 12. Nature 220, 1139 (1968). https://doi.org/10.1038/2201139b0
Received:
Issue date:
DOI: https://doi.org/10.1038/2201139b0
This article is cited by
-
Incidence of antibodies to adenovirus-associated viruses in patients with tumours or other diseases
Archiv f�r die gesamte Virusforschung (1970)